In a move to further secure the health of millions, the World Health Organization (WHO) has reaffirmed its commitment to strengthening Nigeria’s pharmaceutical regulatory framework, ensuring that life-saving medicines and diagnostics meet rigorous international safety standards.
Strategic Collaboration for Public Health
The commitment was highlighted during a high-level meeting between Dr. Pavel Ursu, WHO Representative (acting), and Professor Mojisola Adeyeye, Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC). The discussions focused on sustaining Nigeria’s recent regulatory advancements and expanding access to quality-assured essential medicines across all communities.
The partnership aims to streamline the approval process, allowing for faster assessment of diagnostics without compromising the stringent quality controls that protect Nigerian families from counterfeit or substandard products.
A Milestone in Global Benchmarking
A central point of the report is Nigeria’s sustained achievement of the WHO Global Benchmarking Maturity Level 3. This classification signifies that the country has a stable, well-functioning, and integrated regulatory system.
“Behind every approved medicine is a system working to protect families, strengthen trust, and expand access to essential care,” stated Dr. Pavel Ursu during the briefing. “WHO continues to support Nigeria in strengthening its regulatory system so that medicines and diagnostics are assessed faster, meet the highest quality standards, and earn the full confidence of the public.”
Strengthening Systems through Partnership
The progress seen in Nigeria’s regulatory landscape is the result of a coordinated effort between national leadership and international stakeholders. The WHO extended its appreciation to the Federal Government of Nigeria, alongside key partners including the Bill & Melinda Gates Foundation, The Global Fund, and UNICEF.
These collaborations are viewed as essential for maintaining regulatory impact, ensuring that the last mile of healthcare delivery actual patient access to treatment is backed by a system that guarantees efficacy and safety.
Share this
